492 related articles for article (PubMed ID: 15557131)
41. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.
Laterre PF; Garber G; Levy H; Wunderink R; Kinasewitz GT; Sollet JP; Maki DG; Bates B; Yan SC; Dhainaut JF;
Crit Care Med; 2005 May; 33(5):952-61. PubMed ID: 15891319
[TBL] [Abstract][Full Text] [Related]
42. Hydrocortisone therapy for patients with septic shock.
Sprung CL; Annane D; Keh D; Moreno R; Singer M; Freivogel K; Weiss YG; Benbenishty J; Kalenka A; Forst H; Laterre PF; Reinhart K; Cuthbertson BH; Payen D; Briegel J;
N Engl J Med; 2008 Jan; 358(2):111-24. PubMed ID: 18184957
[TBL] [Abstract][Full Text] [Related]
43. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors.
Schelling G; Stoll C; Kapfhammer HP; Rothenhäusler HB; Krauseneck T; Durst K; Haller M; Briegel J
Crit Care Med; 1999 Dec; 27(12):2678-83. PubMed ID: 10628609
[TBL] [Abstract][Full Text] [Related]
44. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
45. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.
Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E
Crit Care; 2007; 11(1):R21. PubMed ID: 17306016
[TBL] [Abstract][Full Text] [Related]
46. Postoperative Hydrocortisone Infusion Reduces the Prevalence of Low Cardiac Output Syndrome After Neonatal Cardiopulmonary Bypass.
Robert SM; Borasino S; Dabal RJ; Cleveland DC; Hock KM; Alten JA
Pediatr Crit Care Med; 2015 Sep; 16(7):629-36. PubMed ID: 25901540
[TBL] [Abstract][Full Text] [Related]
47. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
Venkatesh B; Myburgh J; Finfer S; Webb SA; Cohen J; Bellomo R; McArthur C; Joyce CJ; Rajbhandari D; Glass P; Harward M;
Crit Care Resusc; 2013 Jun; 15(2):83-8. PubMed ID: 23931038
[TBL] [Abstract][Full Text] [Related]
48. The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.
Viasus D; Garcia-Vidal C; Simonetti AF; Dorca J; Llopis F; Mestre M; Morandeira-Rego F; Carratalà J
BMJ Open; 2015 Jan; 5(1):e006251. PubMed ID: 25564143
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
50. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of methylprednisolone in children with severe community acquired pneumonia.
Nagy B; Gaspar I; Papp A; Bene Z; Nagy B; Voko Z; Balla G
Pediatr Pulmonol; 2013 Feb; 48(2):168-75. PubMed ID: 22588852
[TBL] [Abstract][Full Text] [Related]
52. Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update.
Horita N; Otsuka T; Haranaga S; Namkoong H; Miki M; Miyashita N; Higa F; Takahashi H; Yoshida M; Kohno S; Kaneko T
Sci Rep; 2015 Sep; 5():14061. PubMed ID: 26374694
[TBL] [Abstract][Full Text] [Related]
53. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia.
Ailani RK; Agastya G; Ailani RK; Mukunda BN; Shekar R
Arch Intern Med; 1999 Feb; 159(3):266-70. PubMed ID: 9989538
[TBL] [Abstract][Full Text] [Related]
54. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis.
Rangappa P; Moran JL
Crit Care Resusc; 2009 Jun; 11(2):102-9. PubMed ID: 19485873
[TBL] [Abstract][Full Text] [Related]
55. [In adults admitted to the intensive care unit for severe community-acquired pneumonia, does adding hydrocortisone to standard treatment reduce 28-days mortality compared to placebo, and is it safe?].
Lanthier L; Mayette M; Plourde MÉ; Cauchon M
Rev Med Interne; 2023 Jul; 44(7):383-384. PubMed ID: 37183146
[No Abstract] [Full Text] [Related]
56. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
[TBL] [Abstract][Full Text] [Related]
57. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
[TBL] [Abstract][Full Text] [Related]
58. Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Glass P; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J
Anesthesiology; 2019 Dec; 131(6):1292-1300. PubMed ID: 31651531
[TBL] [Abstract][Full Text] [Related]
59. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
Dremsizov T; Clermont G; Kellum JA; Kalassian KG; Fine MJ; Angus DC
Chest; 2006 Apr; 129(4):968-78. PubMed ID: 16608946
[TBL] [Abstract][Full Text] [Related]
60. Fluid balance correlates with clinical course of multiple organ dysfunction syndrome and mortality in patients with septic shock.
Huang AC; Lee TY; Ko MC; Huang CH; Wang TY; Lin TY; Lin SM
PLoS One; 2019; 14(12):e0225423. PubMed ID: 31790451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
